New study finds GLP-1 agonists and SGLT2 inhibitors associated with reduced risk of dementia in type 2 diabetes patients compared to other glucose-lowering medications.
A novel CSF protein ratio, YWHAG:NPTX2, outperforms traditional biomarkers in predicting cognitive resilience vs progressive cognitive impairment in patients with Alzheimer's disease.
Sipavibart reduced symptomatic COVID-19 by 34.9% compared to standard treatment, but efficacy was only observed against non–Phe456Leu-containing variants, according to new phase 3 trial data.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Research reveals significant associations between environmental microplastic pollution and increased rates of hypertension, diabetes, and stroke across U.S. coastal communities, with pollution levels ranking among top predictors for chronic disease prevalence.
"Sex differences in the pathological progression of AD call for sex-specific timing considerations when administrating anti-Aβ and anti-tau treatments."
New research validates a remote olfactory assessment that successfully identifies cognitive impairment and may provide a cost-effective screening tool for preclinical Alzheimer's disease and other neurodegenerative disorders.